CVS logo

CVS Health (CVS) EBITDA

annual EBITDA:

$13.70B-$4.49B(-24.70%)
December 31, 2024

Summary

  • As of today (May 21, 2025), CVS annual EBITDA is $13.70 billion, with the most recent change of -$4.49 billion (-24.70%) on December 31, 2024.
  • During the last 3 years, CVS annual EBITDA has fallen by -$3.82 billion (-21.81%).
  • CVS annual EBITDA is now -24.70% below its all-time high of $18.20 billion, reached on December 31, 2023.

Performance

CVS EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCVSincome statement metrics

quarterly EBITDA:

$4.56B+$525.00M(+13.02%)
March 31, 2025

Summary

  • As of today (May 21, 2025), CVS quarterly EBITDA is $4.56 billion, with the most recent change of +$525.00 million (+13.02%) on March 31, 2025.
  • Over the past year, CVS quarterly EBITDA has increased by +$1.12 billion (+32.67%).
  • CVS quarterly EBITDA is now -21.81% below its all-time high of $5.83 billion, reached on June 30, 2020.

Performance

CVS quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCVSincome statement metrics

TTM EBITDA:

$14.82B+$1.12B(+8.19%)
March 31, 2025

Summary

  • As of today (May 21, 2025), CVS TTM EBITDA is $14.82 billion, with the most recent change of +$1.12 billion (+8.19%) on March 31, 2025.
  • Over the past year, CVS TTM EBITDA has dropped by -$2.34 billion (-13.62%).
  • CVS TTM EBITDA is now -20.13% below its all-time high of $18.56 billion, reached on June 30, 2020.

Performance

CVS TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCVSincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

CVS EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-24.7%+32.7%-13.6%
3 y3 years-21.8%-1.7%-14.8%
5 y5 years-16.5%-0.9%-13.7%

CVS EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-24.7%+11.0%-21.4%+261.1%-19.5%+38.0%
5 y5-year-24.7%+11.0%-21.8%+261.1%-20.1%+38.0%
alltimeall time-24.7%+2895.8%-21.8%+216.8%-20.1%+517.2%

CVS EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$4.56B(+13.0%)
$14.82B(+8.2%)
Dec 2024
$13.70B(-24.7%)
$4.03B(+99.8%)
$13.70B(-3.5%)
Sep 2024
-
$2.02B(-52.2%)
$14.20B(-16.6%)
Jun 2024
-
$4.22B(+22.9%)
$17.02B(-0.8%)
Mar 2024
-
$3.43B(-24.2%)
$17.16B(-5.7%)
Dec 2023
$18.20B(+47.4%)
$4.53B(-6.4%)
$18.20B(-1.2%)
Sep 2023
-
$4.84B(+11.0%)
$18.41B(+71.3%)
Jun 2023
-
$4.36B(-2.4%)
$10.75B(-11.8%)
Mar 2023
-
$4.47B(-5.8%)
$12.18B(-1.4%)
Dec 2022
$12.35B(-29.6%)
$4.75B(-267.8%)
$12.35B(+12.4%)
Sep 2022
-
-$2.83B(-148.8%)
$10.99B(-37.9%)
Jun 2022
-
$5.79B(+25.0%)
$17.70B(+1.6%)
Mar 2022
-
$4.64B(+37.0%)
$17.41B(-0.7%)
Dec 2021
$17.53B(+2.4%)
$3.38B(-12.8%)
$17.53B(+2.0%)
Sep 2021
-
$3.88B(-29.5%)
$17.18B(+1.4%)
Jun 2021
-
$5.51B(+15.9%)
$16.95B(-1.8%)
Mar 2021
-
$4.75B(+56.2%)
$17.27B(+0.9%)
Dec 2020
$17.12B(+4.4%)
$3.04B(-16.7%)
$17.12B(-6.2%)
Sep 2020
-
$3.65B(-37.3%)
$18.24B(-1.7%)
Jun 2020
-
$5.83B(+26.7%)
$18.56B(+8.1%)
Mar 2020
-
$4.60B(+10.4%)
$17.17B(+4.7%)
Dec 2019
$16.40B(+143.3%)
$4.16B(+4.8%)
$16.40B(+18.2%)
Sep 2019
-
$3.97B(-10.4%)
$13.88B(+5.9%)
Jun 2019
-
$4.43B(+15.7%)
$13.10B(+65.1%)
Mar 2019
-
$3.83B(+133.4%)
$7.94B(+17.7%)
Dec 2018
$6.74B(-42.9%)
$1.64B(-48.6%)
$6.74B(-23.7%)
Sep 2018
-
$3.19B(-538.0%)
$8.84B(+3.1%)
Jun 2018
-
-$729.00M(-127.6%)
$8.57B(-28.8%)
Mar 2018
-
$2.64B(-29.4%)
$12.04B(+1.9%)
Dec 2017
$11.81B(-3.1%)
$3.73B(+27.6%)
$11.81B(+0.9%)
Sep 2017
-
$2.93B(+6.9%)
$11.70B(-3.3%)
Jun 2017
-
$2.74B(+13.5%)
$12.11B(+2.6%)
Mar 2017
-
$2.41B(-33.6%)
$11.80B(-3.2%)
Dec 2016
$12.19B(+5.4%)
$3.63B(+8.9%)
$12.19B(+2.6%)
Sep 2016
-
$3.33B(+37.1%)
$11.88B(+4.0%)
Jun 2016
-
$2.43B(-13.1%)
$11.42B(-2.8%)
Mar 2016
-
$2.80B(-15.6%)
$11.74B(+1.5%)
Dec 2015
$11.57B(+13.1%)
$3.32B(+15.6%)
$11.57B(+4.5%)
Sep 2015
-
$2.87B(+4.2%)
$11.06B(+6.4%)
Jun 2015
-
$2.75B(+5.0%)
$10.40B(+0.5%)
Mar 2015
-
$2.63B(-6.7%)
$10.35B(+1.2%)
Dec 2014
$10.22B(+3.1%)
$2.81B(+27.5%)
$10.22B(+1.3%)
Sep 2014
-
$2.21B(-18.2%)
$10.09B(-3.9%)
Jun 2014
-
$2.70B(+7.8%)
$10.50B(+2.7%)
Mar 2014
-
$2.50B(-6.5%)
$10.22B(+3.1%)
Dec 2013
$9.91B(+15.0%)
$2.68B(+2.3%)
$9.91B(+2.9%)
Sep 2013
-
$2.62B(+8.1%)
$9.63B(+3.9%)
Jun 2013
-
$2.42B(+10.2%)
$9.27B(+3.1%)
Mar 2013
-
$2.20B(-8.3%)
$8.99B(+4.3%)
Dec 2012
$8.62B(+9.1%)
$2.40B(+6.1%)
$8.62B(+0.5%)
Sep 2012
-
$2.26B(+5.6%)
$8.58B(+3.2%)
Jun 2012
-
$2.14B(+17.0%)
$8.31B(+3.3%)
Mar 2012
-
$1.83B(-22.4%)
$8.05B(+1.9%)
Dec 2011
$7.90B(+3.9%)
$2.35B(+18.2%)
$7.90B(+2.9%)
Sep 2011
-
$1.99B(+6.2%)
$7.68B(+1.9%)
Jun 2011
-
$1.88B(+11.7%)
$7.54B(+0.1%)
Mar 2011
-
$1.68B(-21.3%)
$7.53B(-1.2%)
Dec 2010
$7.61B(-2.7%)
$2.13B(+15.4%)
$7.62B(-1.3%)
Sep 2010
-
$1.85B(-1.1%)
$7.72B(-0.2%)
Jun 2010
-
$1.87B(+5.7%)
$7.74B(-1.4%)
Mar 2010
-
$1.77B(-20.9%)
$7.86B(+0.5%)
Dec 2009
$7.82B(+6.5%)
$2.23B(+19.6%)
$7.82B(+1.9%)
Sep 2009
-
$1.87B(-5.8%)
$7.68B(+1.1%)
Jun 2009
-
$1.98B(+14.4%)
$7.59B(+2.6%)
Mar 2009
-
$1.73B(-17.2%)
$7.40B(+0.9%)
Dec 2008
$7.34B(+24.7%)
$2.09B(+17.4%)
$7.33B(+4.9%)
Sep 2008
-
$1.78B(-0.6%)
$6.99B(+3.1%)
Jun 2008
-
$1.79B(+7.3%)
$6.79B(+2.6%)
Mar 2008
-
$1.67B(-4.7%)
$6.61B(+12.3%)
Dec 2007
$5.89B(+85.5%)
$1.75B(+11.4%)
$5.89B(+15.8%)
Sep 2007
-
$1.57B(-2.8%)
$5.09B(+19.9%)
Jun 2007
-
$1.62B(+71.1%)
$4.24B(+24.7%)
Mar 2007
-
$945.30M(-0.6%)
$3.40B(+7.2%)
Dec 2006
$3.17B(+21.7%)
$950.70M(+30.2%)
$3.17B(+6.4%)
Sep 2006
-
$730.20M(-6.2%)
$2.98B(+5.1%)
Jun 2006
-
$778.10M(+8.7%)
$2.84B(+5.7%)
Mar 2006
-
$715.90M(-5.7%)
$2.69B(+3.0%)
Dec 2005
$2.61B(+33.7%)
$759.00M(+29.4%)
$2.61B(+9.4%)
Sep 2005
-
$586.60M(-6.2%)
$2.38B(+6.8%)
Jun 2005
-
$625.30M(-1.9%)
$2.23B(+6.8%)
Mar 2005
-
$637.70M(+19.3%)
$2.09B(+7.1%)
Dec 2004
$1.95B
$534.60M(+23.0%)
$1.95B(+0.4%)
DateAnnualQuarterlyTTM
Sep 2004
-
$434.60M(-10.1%)
$1.94B(+1.7%)
Jun 2004
-
$483.30M(-3.1%)
$1.91B(+3.3%)
Mar 2004
-
$499.00M(-5.2%)
$1.85B(+4.8%)
Dec 2003
$1.77B(+16.4%)
$526.50M(+30.8%)
$1.77B(+6.8%)
Sep 2003
-
$402.50M(-4.7%)
$1.65B(+3.0%)
Jun 2003
-
$422.40M(+2.1%)
$1.60B(+2.9%)
Mar 2003
-
$413.90M(-0.1%)
$1.56B(+2.8%)
Dec 2002
$1.52B(+5.0%)
$414.30M(+17.2%)
$1.52B(+11.3%)
Sep 2002
-
$353.60M(-6.2%)
$1.36B(+4.0%)
Jun 2002
-
$377.10M(+1.5%)
$1.31B(-3.3%)
Mar 2002
-
$371.50M(+42.4%)
$1.36B(-6.1%)
Dec 2001
$1.44B(-10.8%)
$260.80M(-13.3%)
$1.44B(-11.3%)
Sep 2001
-
$300.90M(-28.7%)
$1.63B(-3.5%)
Jun 2001
-
$422.20M(-8.2%)
$1.69B(+0.9%)
Mar 2001
-
$460.00M(+3.2%)
$1.67B(+3.3%)
Dec 2000
$1.62B(+14.6%)
$445.60M(+23.9%)
$1.62B(+2.7%)
Sep 2000
-
$359.70M(-11.7%)
$1.58B(+4.6%)
Jun 2000
-
$407.30M(+0.1%)
$1.51B(+3.3%)
Mar 2000
-
$406.70M(+0.8%)
$1.46B(+3.2%)
Dec 1999
$1.41B(+19.8%)
$403.50M(+39.2%)
$1.41B(+5.4%)
Sep 1999
-
$289.80M(-19.3%)
$1.34B(+2.9%)
Jun 1999
-
$358.90M(-0.6%)
$1.30B(+5.2%)
Mar 1999
-
$361.20M(+9.1%)
$1.24B(+5.0%)
Dec 1998
$1.18B(+24.7%)
$331.00M(+31.1%)
$1.18B(+4.0%)
Sep 1998
-
$252.50M(-14.1%)
$1.13B(+2.5%)
Jun 1998
-
$294.10M(-2.8%)
$1.11B(+13.7%)
Mar 1998
-
$302.60M(+5.9%)
$973.90M(+6.2%)
Dec 1997
$946.70M(+9.1%)
$285.70M(+26.9%)
$916.90M(-25.4%)
Sep 1997
-
$225.10M(+40.2%)
$1.23B(+14.0%)
Jun 1997
-
$160.50M(-34.6%)
$1.08B(-4.7%)
Mar 1997
-
$245.60M(-58.9%)
$1.13B(+19.3%)
Dec 1996
$867.50M(+19.8%)
$597.90M(+702.6%)
$948.30M(+14.4%)
Sep 1996
-
$74.50M(-65.1%)
$828.60M(-1.0%)
Jun 1996
-
$213.30M(+240.7%)
$837.10M(+9.7%)
Mar 1996
-
$62.60M(-86.9%)
$762.90M(+5.4%)
Dec 1995
$723.90M(-11.4%)
$478.20M(+476.1%)
$724.00M(+2.5%)
Sep 1995
-
$83.00M(-40.3%)
$706.40M(-9.5%)
Jun 1995
-
$139.10M(+486.9%)
$780.50M(-0.3%)
Mar 1995
-
$23.70M(-94.9%)
$782.60M(-4.4%)
Dec 1994
$817.00M(+0.3%)
$460.60M(+193.2%)
$818.30M(-0.4%)
Sep 1994
-
$157.10M(+11.3%)
$821.50M(+2.7%)
Jun 1994
-
$141.20M(+137.7%)
$800.10M(-6.4%)
Mar 1994
-
$59.40M(-87.2%)
$854.70M(+4.9%)
Dec 1993
$814.90M(+45.0%)
$463.80M(+241.8%)
$814.80M(+52.2%)
Sep 1993
-
$135.70M(-30.7%)
$535.30M(-3.4%)
Jun 1993
-
$195.80M(+904.1%)
$554.00M(+0.4%)
Mar 1993
-
$19.50M(-89.4%)
$551.70M(-1.9%)
Dec 1992
$561.90M(-30.5%)
$184.30M(+19.4%)
$562.10M(-33.5%)
Sep 1992
-
$154.40M(-20.2%)
$845.70M(+0.9%)
Jun 1992
-
$193.50M(+547.2%)
$838.10M(+5.3%)
Mar 1992
-
$29.90M(-93.6%)
$795.80M(-1.5%)
Dec 1991
$808.10M(+3.8%)
$467.90M(+218.7%)
$808.10M(+6.1%)
Sep 1991
-
$146.80M(-2.9%)
$761.40M(+0.1%)
Jun 1991
-
$151.20M(+258.3%)
$760.80M(-2.1%)
Mar 1991
-
$42.20M(-90.0%)
$777.10M(-0.2%)
Dec 1990
$778.60M(+2.6%)
$421.20M(+188.1%)
$778.30M(+1.1%)
Sep 1990
-
$146.20M(-12.7%)
$769.60M(-0.4%)
Jun 1990
-
$167.50M(+285.9%)
$772.50M(+5.0%)
Mar 1990
-
$43.40M(-89.5%)
$735.80M(-3.0%)
Dec 1989
$758.70M(+12.9%)
$412.50M(+176.7%)
$758.70M(-121.4%)
Sep 1989
-
$149.10M(+14.0%)
-$3.55B(+71.0%)
Jun 1989
-
$130.80M(+97.3%)
-$2.08B(+181.4%)
Mar 1989
-
$66.30M(-101.7%)
-$738.30M(-225.2%)
Dec 1988
$671.80M(+12.8%)
-$3.90B(-340.0%)
$589.60M(-46.2%)
Sep 1988
-
$1.62B(+10.5%)
$1.10B(+26.8%)
Jun 1988
-
$1.47B(+5.5%)
$865.10M(+2.5%)
Mar 1988
-
$1.39B(-141.1%)
$843.90M(+61.2%)
Dec 1987
$595.60M(+8.8%)
-$3.39B(-343.5%)
$523.60M(-39.6%)
Sep 1987
-
$1.39B(-3.9%)
$866.80M(+18.2%)
Jun 1987
-
$1.45B(+34.9%)
$733.60M(+38.6%)
Mar 1987
-
$1.07B(-135.2%)
$529.30M(+9.5%)
Dec 1986
$547.60M(+6.9%)
-$3.05B(-342.0%)
$483.40M(-39.2%)
Sep 1986
-
$1.26B(+1.2%)
$795.50M(+17.7%)
Jun 1986
-
$1.24B(+21.1%)
$676.10M(+16.1%)
Mar 1986
-
$1.03B(-137.6%)
$582.50M(+29.7%)
Dec 1985
$512.10M(+12.0%)
-$2.74B(-340.0%)
$449.00M(-25.6%)
Sep 1985
-
$1.14B(-0.9%)
$603.80M(+14.1%)
Jun 1985
-
$1.15B(+28.7%)
$529.30M(+14.5%)
Mar 1985
-
$894.50M(-134.6%)
$462.10M(+16.1%)
Dec 1984
$457.40M
-$2.58B(-342.3%)
$398.10M(-86.6%)
Sep 1984
-
$1.07B(-1.7%)
$2.98B(+55.7%)
Jun 1984
-
$1.08B(+30.5%)
$1.91B(+130.5%)
Mar 1984
-
$830.50M
$830.50M

FAQ

  • What is CVS Health annual EBITDA?
  • What is the all time high annual EBITDA for CVS Health?
  • What is CVS Health annual EBITDA year-on-year change?
  • What is CVS Health quarterly EBITDA?
  • What is the all time high quarterly EBITDA for CVS Health?
  • What is CVS Health quarterly EBITDA year-on-year change?
  • What is CVS Health TTM EBITDA?
  • What is the all time high TTM EBITDA for CVS Health?
  • What is CVS Health TTM EBITDA year-on-year change?

What is CVS Health annual EBITDA?

The current annual EBITDA of CVS is $13.70B

What is the all time high annual EBITDA for CVS Health?

CVS Health all-time high annual EBITDA is $18.20B

What is CVS Health annual EBITDA year-on-year change?

Over the past year, CVS annual EBITDA has changed by -$4.49B (-24.70%)

What is CVS Health quarterly EBITDA?

The current quarterly EBITDA of CVS is $4.56B

What is the all time high quarterly EBITDA for CVS Health?

CVS Health all-time high quarterly EBITDA is $5.83B

What is CVS Health quarterly EBITDA year-on-year change?

Over the past year, CVS quarterly EBITDA has changed by +$1.12B (+32.67%)

What is CVS Health TTM EBITDA?

The current TTM EBITDA of CVS is $14.82B

What is the all time high TTM EBITDA for CVS Health?

CVS Health all-time high TTM EBITDA is $18.56B

What is CVS Health TTM EBITDA year-on-year change?

Over the past year, CVS TTM EBITDA has changed by -$2.34B (-13.62%)
On this page